glp 1 receptor agonist GLP-1 Agonists as Treatments for Type 2 Diabetes GLP-1 receptor agonists and next-generation

Why it matters: Wellness peptides (often promoted for injury recovery, weight loss, muscle gain, and anti-aging) are already popular even though most lack human testing and arent legally marketed as consumer health products

Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT)

J., Saris, W

Additional research has also demonstrated that professional carnitine administration can be used to lower clinically high blood pressure levels, treat congestive heart failure, manage cardiac ischemia (the restriction of blood flow to the heart), and peripheral arterial diseases, a condition characterized primarily by poor circulation in the legs (known as intermittent claudication)

J Control Release [Internet]

doi: 10.3390/molecules18055125 15 ChenT.XiaoL.ZhuL.MaS.YanT.JiH